Use of antidepressants among children and adolescents 2004 -06 - Did the warnings lead to fewer prescriptions?;Antidepressiver hos barn og ungdom - Førte advarsler til færre forskrivninger?

Tidsskrift for den Norske Laegeforening

Volumn 127, Issue 20, 2007, Pages 2653-2655

  Bramness, Jørgen G ^a   Engeland, Anders ^b,c   Furu, Kari ^b  

^a Avdeling for Legemiddelepidemiologi   (Norway)

^b Universitetet I Bergen ^*

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CYCLOHEXANOL DERIVATIVE; FLUOXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; COMPARATIVE STUDY; DRUG UTILIZATION; FEMALE; HUMAN; MALE; PRESCRIPTION; RISK FACTOR; STATISTICS;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CHILD; CYCLOHEXANOLS; DRUG UTILIZATION; FEMALE; FLUOXETINE; HUMANS; MALE; PRESCRIPTIONS, DRUG; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS;

EID: 35848939380     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Mann JJ, Emslie G, Baldessarini RJ et al. ACNP Task Force report on SSRIs and suicidal behavior in youth. Neuropsychopharmacology 2006; 31: 473-92.
2. Whittington CJ, Kendall T, Fonagy P et al. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 2004; 363: 1341-5.
3. Olfson M, Marcus S, Shaffer D. Antidepressant drug therapy and suicide in severely depressed children and adults. Arch Gen Psychiatry 2006; 63: 865-72.
4. Bridge JA, Iyengar S, Salary CB et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 2007; 297: 1683-96.
5. Courtney DB. Selective serotonin reuptake inhibitor and venlafaxine use in children and adolescents with major depressive disorder: a systematic review of published randomized controlled trials. Can J Psychiatry 2004; 49: 557-63.
6. Wong IC, Besag FM, Santosh PJ et al. Use of selective serotonin reuptake inhibitors in children and adolescents. Drug Saf 2004; 27: 991-1000.
7. Statens legemiddelverk. Oppdatert terapianbefaling: depresjon hos barn og ungdom www.legemiddelverket. no/templates/InterPage_15923.aspx (24.7.2007).
8. Thomsen PH, Sørensen MJ. Hvilken evidens er der for medikamentel behandling af depression hos børn og unge? Ugeskr Læger 2007; 169: 1289-94. (www.ugeskriftet.dk/LF/UFL/2007/14/pdf/VP47129.pdf (24.7.2007).)
9. Furu K. Drug utilisation in a public health perspective: Establishing a national prescription register in Norway. Nor J Epidemiol 2001; 11: 55-60. (www.ub.ntnu.no/journals/norepid/2001-1/2001(1)Furu.pdf (24.7.2007).)
10. Bramness JG, Hausken AM, Sakshaug S et al. Forskrivning av selektive serotoninreopptakshemmere 1990-2004. Tidsskr Nor Lægeforen 2005; 125: 2470-3.
11. Zito JM, Tobi H, de Jong-van den Berg LT et al. Antidepressant prevalence for youths: a multinational comparison. Pharmacoepidemiol Drug Saf 2006; 15: 793-8.
12. Murray M, de Vries C, Wong I. A drug utilisation study of antidepressants in children and adolescents using the general practice research database. Arch Dis Child 2004; 89: 1098-102.
13. Clavenna A, Rossi E, Derosa M et al. Use of psychotropic medications in Italian children and adolescents. Eur J Pediatr 2007; 166: 339-47.
14. Nemeroff CB, Kalali A, Keller MB et al. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States. Arch Gen Psychiatry 2007; 64: 466-72.
15. Grimshaw JM, Thomas RE, MacLennan G et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004; 8: III-IV, 1-72.
16. Molaug PO, Spigset O. Ett års skriftlig legemiddelinformasjon til en kommunelege. Tidsskr Nor Lægeforen 2001; 121: 585-8.